Ekaitz Agirregoitia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ekaitz Agirregoitia has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Naiara Agirregoitia
Department of Physiology, Faculty of Medicine and Dentistry, University of the Basque Country, Leioa, Spain; BioCruces Health Research Institute, Barakaldo, Spain
3 shared publicationsAntonia Expósito
BioCruces Health Research Institute, Barakaldo, Spain; Human Reproduction Unity, Department of Obstetrics and Gynecology, Cruces University Hospital, University of the Basque Country, Barakaldo, Spain
2 shared publications- Arkaitz Carracedo
Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA) Derio Spain
2 shared publications Asier Valdivia
2 shared publications- Jon Irazusta
Ageing On Research Group, Department of Physiology, University of the Basque Country (EHU), Leioa, Spain
2 shared publications Laura Peralta
2 shared publications
Latest Publications
- Open Access
- 3 July 2026
- Published by Elsevier in Journal of Psychosomatic Research
- Vol. 210, 112917
Biopsychosocial outcomes and quality of life in assisted reproduction: Conventional IVF versus in vitro maturation in women with PMOS
- 3 July 2026
- Published by Elsevier in Journal of Psychosomatic Research
- Vol. 210, 112917
Open AccessBiopsychosocial outcomes and quality of life in assisted reproduction: Conventional IVF versus in vitro maturation in women with PMOS
- 1 September 2015
- Published by Elsevier in Fertility and Sterility
- Vol. 104 (3) , 753-760
Dynamics of expression and localization of the cannabinoid system in granulosa cells during oocyte nuclear maturation
- 1 September 2015
- Published by Elsevier in Fertility and Sterility
- Vol. 104 (3) , 753-760
Dynamics of expression and localization of the cannabinoid system in granulosa cells during oocyte nuclear maturation
- 1 May 2012
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 24 (5) , 550-557
Expression and localization of opioid receptors during the maturation of human oocytes
- 1 May 2012
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 24 (5) , 550-557
Expression and localization of opioid receptors during the maturation of human oocytes
- 1 March 2010
- Published by Elsevier in Fertility and Sterility
- Vol. 93 (5) , 1378-1387
The CB2 cannabinoid receptor regulates human sperm cell motility
- 1 March 2010
- Published by Elsevier in Fertility and Sterility
- Vol. 93 (5) , 1378-1387
The CB2 cannabinoid receptor regulates human sperm cell motility
- Open Access
- 1 December 2006
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 91 (12) , 4969-4975
Expression and Localization of δ-, κ-, and μ-Opioid Receptors in Human Spermatozoa and Implications for Sperm Motility
Context: Endogenous opioid peptides signal through δ-, κ-, and μ-opioid receptors. Some of these peptides such as endorphins and enkephalins are present in the male reproductive tract, but the presence of the corresponding receptors in human sperm cells has not yet been reported. Objective: Our objective was to study the expression and localization of δ-, κ-, and μ-opioid receptors on human spermatozoa and the implication in sperm motility. Methods: The expression of receptors was studied by RT-PCR, Western blot, and immunofluorescence techniques. We evaluated the effects of activation of each opioid receptor by specific agonist and antagonist. Results: Human spermatozoa express δ-, κ-, and μ-opioid receptors. These receptors were located in different parts of the head, in the middle region, and in the tail of the sperm. Progressive motility of spermatozoa, an important parameter to evaluate male fertility, was found to be significantly reduced after incubation with the μ-receptor agonist morphine, whereas this effect was antagonized in the presence of the corresponding antagonist naloxone. The δ-receptor antagonist naltrindole significantly reduced progressive motility immediately after its addition. However, the δ-receptor agonist DPDPE had no significant effect. Finally, neither the κ-receptor agonist U50488 nor its antagonist nor-binaltorphimine significantly affected the progressive motility of human spermatozoa. Conclusion: We report for first time the presence of functional δ-, κ-, and μ-opioid receptors in human sperm membranes. These findings are indicative of a role for the opioid system in the regulation of sperm physiology.
- 1 December 2006
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 91 (12) , 4969-4975
Open AccessExpression and Localization of δ-, κ-, and μ-Opioid Receptors in Human Spermatozoa and Implications for Sperm Motility
Context: Endogenous opioid peptides signal through δ-, κ-, and μ-opioid receptors. Some of these peptides such as endorphins and enkephalins are present in the male reproductive tract, but the presence of the corresponding receptors in human sperm cells has not yet been reported. Objective: Our objective was to study the expression and localization of δ-, κ-, and μ-opioid receptors on human spermatozoa and the implication in sperm motility. Methods: The expression of receptors was studied by RT-PCR, Western blot, and immunofluorescence techniques. We evaluated the effects of activation of each opioid receptor by specific agonist and antagonist. Results: Human spermatozoa express δ-, κ-, and μ-opioid receptors. These receptors were located in different parts of the head, in the middle region, and in the tail of the sperm. Progressive motility of spermatozoa, an important parameter to evaluate male fertility, was found to be significantly reduced after incubation with the μ-receptor agonist morphine, whereas this effect was antagonized in the presence of the corresponding antagonist naloxone. The δ-receptor antagonist naltrindole significantly reduced progressive motility immediately after its addition. However, the δ-receptor agonist DPDPE had no significant effect. Finally, neither the κ-receptor agonist U50488 nor its antagonist nor-binaltorphimine significantly affected the progressive motility of human spermatozoa. Conclusion: We report for first time the presence of functional δ-, κ-, and μ-opioid receptors in human sperm membranes. These findings are indicative of a role for the opioid system in the regulation of sperm physiology.